Galactose-modified cationic liposomes as a liver-targeting delivery system for small interfering RNA

Biological and Pharmaceutical Bulletin

Volumn 34, Issue 8, 2011, Pages 1338-1342

  Sonoke, Satoru ^a   Ueda, Toshihiro ^a   Fujiwara, Kae ^a   Kuwabara, Kenji ^a   Yano, Junichi ^a  

^a NIPPON SHINYAKU CO LTD   (Japan)

Author keywords

Cationic liposome; Drug delivery; Galactose; Hepatocyte; Small interfering RNA

Indexed keywords

GALACTOSE; LIPOSOME; SMALL INTERFERING RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL STRAIN HEPG2; CELL TRANSPORT; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; GENE SILENCING; IN VITRO STUDY; IN VIVO STUDY; LIPOSOMAL GENE DELIVERY SYSTEM; LIVER PARENCHYMA; LIVER PERFUSION; MALE; MOUSE; NONHUMAN; PARTICLE SIZE; RADIOACTIVITY;

ANIMALS; ASIALOGLYCOPROTEIN RECEPTOR; CARCINOMA, HEPATOCELLULAR; CATIONS; CELL LINE, TUMOR; DRUG CARRIERS; GALACTOSE; GENE SILENCING; HUMANS; LIPIDS; LIPOSOMES; LIVER; MALE; MICE; MICE, INBRED BALB C; PHOSPHATIDYLETHANOLAMINES; RNA, SMALL INTERFERING;

EID: 80051509854     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.34.1338     Document Type: Article

References (18)

1. Fire A., Xu S., Montgomery M. K., Kostas S. A., Driver S. E., Mello C. C., Nature (London), 391, 806-811 (1998).
2. Elbashir S. M., Harborth J., Lendeckel W., Yalcin A., Weber K., Tuschl T., Nature (London), 411, 494-498 (2001).
3. Novina C. D., Sharp P. A., Nature (London), 430, 161-164 (2004).
4. Shen J., Samul R., Silva R. L., Akiyama H., Liu H., Saishin Y., Hackett S. F., Zinnen S., Kossen K., Fosnaugh K., Vargeese C., Gomez A., Bouhana K., Aitchison R., Pavco P., Campochiaro P. A., Gene Ther., 13, 225-234 (2006).
5. Xie F. Y., Woodle M. C., Lu P. Y., Drug Discov. Today, 11, 67-73 (2006).
6. Lu P. Y., Xie F. Y., Woodle M. C., Trends Mol. Med., 11, 104-113 (2005).
7. Hashida M., Kawakami S., Yamashita F., Chem. Pharm. Bull., 53, 871-880 (2005).
8. Spiess M., Biochemistry, 29, 10009-10018 (1990).
9. Hirabayashi K., Yano J., Inoue T., Yamaguchi T., Tanigawara K., Smyth G. E., Ishiyama K., Ohgi T., Kimura K., Irimura T., Cancer Res., 59, 4325-4333 (1999).
10. Sonoke S., Ueda T., Fujiwara K., Sato Y., Takagaki K., Hirabayashi K., Ohgi T., Yano J., Cancer Res., 68, 8843-8851 (2008).
11. Nilsson M., Berg T., Biochim. Biophys. Acta, 497, 171-182 (1977).
12. Chowdhury N. R., Wu C. H., Wu G. Y., Yerneni P. C., Bommineni V. R., Chowdhury J. R., J. Biol. Chem., 268, 11265-11271 (1993).
13. Sternberg B., Hong K., Zheng W., Papahadjopoulos D., Biochim. Biophys. Acta, 1375, 23-35 (1998).
14. Semple S. C., Akinc A., Chen J., Sandhu A. P., Mui B. L., Cho C. K., Sah D. W. Y., Stebbing D., Crosley E. J., Yaworski E., Hafez I. M., Dorkin J. R., Qin J., Lam K., Rajeev K. G., Wong K. F., Jeffs L. B., Nechev L., Eisenhardt M. L., Jayaraman M., Kazem M., Maier M. A., Srinivasulu M., Weinstein M. J., Chen Q., Alvarez R., Barros S. A., De S., Klimuk S. K., Borland T., Kosovrasti V., Cantley W. L., Tam Y. K., Manoharan M., Ciufolini M. A., Tracy M. A., de Fougerolles A., MacLachlan I., Cullis P. R., Madden T. D., Hope M. J., Nat. Biotechnol., 28, 172-176 (2010).
15. Koltover I., Salditt T., Rädler J. O., Safinya C. R., Science, 281, 78-81 (1998).
16. Fadden A. J., Holt O. J., Drickamer K., Glycobiology, 13, 529-537 (2003).
17. Sato A., Takagi M., Shimamoto A., Kawakami S., Hashida M., Biomaterials,28, 1434-1442 (2007).
18. Wang S. L., Yu F. B., Jiang T. Y., Sun C. S., Wang T., Zhang J. H., J. Drug Target., 16, 233-242 (2008).